Opinion on Healthcare in United Kingdom

Published within

« | 1 | 2 | 3 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

UK budget: uncertainty remains over intellectual property legislation

George Osborne, the UK chancellor of the exchequer, has attempted to appease branded pharmaceutical manufacturers in his 2011 budget announcement by introducing lower corporate tax rates and increasing R&D incentives. However, it is still unclear as to whether he will go even further and reform the Bolar exemption, which could harm generic drug producers, and lead to a rise in NHS drug spending.

Published By Datamonitor
25 Mar 2011

« | 1 | 2 | 3 | » »|

No help is available.